Published: 2017-05-27

Study of soft tissue sarcomas over a period of 3 years

Jenna Prabhakar, J. Sushma, B. V. S. Kartheek, A. Bhagya Lakshmi, Chapara Vaibhav


Background: Soft tissue malignancies constituted a heterogeneous group of rare solid tumors of mesenchymal cell origin with distinct clinical and pathological features. The aim of the study was to know the prevalence of soft tissue sarcoma, sex, age and site distribution, histopathology and various treatment options adopted with follow up.

Methods: A total of 26 cases of soft tissue sarcoma were analyzed for a three-year period. Clinical presentation, age and sex distribution, histological type and treatment modalities adopted were recorded and analyzed.

Results: Out of 26 cases 44% of cases were between 30-50 years and 44% of tumors were situated in lower extremity. The commonest histological type was liposarcomas and fibrosarcoma. Lymph node metastasis was seen in 4% of cases. Distant metastasis was present in 3 cases, 2 with lung metastasis and l with lung and liver metastasis. Surgery was the main modality of the treatment. 12% of the cases presented with recurrent tumor, the duration between surgery and recurrence was 6 months. Only 38% turned for follow up, 2 patients succumbed to death because of multiple pulmonary secondaries and chest infections.

Conclusion: In the present study, all the cases of soft tissue sarcoma presented in late stage of the disease due to illiteracy and lack of health education. Recurrence was seen in 12% of cases. The overall survival rates and quality of life of the patients can be improved by frequent health camps at primary health centers for early detection of the disease, providing adequate health education, diagnostic and management facilities.


Histopathology variants, Management, Prevalence, Soft tissue sarcoma

Full Text:



Ross JA, Severson RK, Davis S, Brooks JJ. Trends in the incidence of soft tissue sarcomas in the United States from 1973 through 1987. Cancer. 1993;72:486-90.

Schuurman B, Meyer S, Cuesta MA, Nauta JJ. Increasing frequency of soft tissue sarcomas in the Netherlands. Ned Tijdschr Geneeskd. 1992;136:1556-60.

Levi F, Vecchia CL, Randimbison L, Te VC. Descriptive epidemiology of soft tissue sarcomas in Vaud, Switzerland Eur J Cancer. 1999;35:1711-6.

Gustafson P. soft tissue sarcoma. Epidemiology and prognosis in 508 patients. Acta Orthop Scand Suppl. 1994;259:1-31.

Toro JR, Travis LB, Wu HJ, Zhu K, Fletcher CD, Devesa SS, et al. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978- 2001: an analysis of 26,758 cases. Int J Cancer. 2006;119:2922-30.

Zahm SH, Fraumeni JF Jr. The epidemiology of sofi tissue sarcoma. Semin Oncol. 1997;24:504-14.

Gibson TN, Hanchard B, Waugh N, McNaughton D. A fifty-year review of soft tissue sarcomas in Jamaica: 1958-2007. West Indian Med J. 2012;6l(7):692.

Mandong BM, Kidmas AT, Manasseh AN, Echejoh GO, Tanko MN, Madaki AJ. Epidemiology of sofi tissue sarcomas in Jos, North Central Nigeria. Niger J Med. 2007;16(3):246-9.

Seleye-Fubara D, Nwosu SO, Yellowe BE. Sofi tissue sarcomas in the Niger Delta Region of Nigeria (a referral hospital's study). Niger J Med. 2005;14(2):188-94.

Adeniji KA. Histopathological and histochemical patterns of sofi tissue sarcomas in Ilorin, NigeriaAfi' J Med Med Sci. 2003;32(3):269-73.

Abudu EK, Akinde OR, Oyebadejo TO, Efunshile AM, Musa OA, Banjo AA. Histopathological study of soft tissue malignancies in a teaching hospital, Sagamu, South-West Nigeria. Nig Q J Hosp Med. 2010;20(1):42-5.

Reshadi H, Rouhani A, Mohajerzadeh S, Moosa M, Elmi A. Preva1ence of malignant soft tissue tumors in extremities: an epidemiological study in syria. Arch Bone J Surg. 2014;2(2):106-10.

Kransdorf MJ. Malignantsofi-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location. AJR Am J Roentgenol. 1995;l64(l):129-34.

Wibmer C, Leithner A, Zielonke N, Sperl M, Windhager R. 1ncreasing incidence rates of soft tissue sarcomas? A population-based epidemiologic study and literature review. Ann Oncol. 2010;21(5):1106-11.